Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
Press Releases

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

NEW YORK, March 4, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM),

avatar profile Olean Times Herald

Olean Times Herald


Local & Social